SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Quadmedicine Seeks Korean Approval for Osteoporosis Patch Trial

Quadmedicine applied for Korean approval to begin a Phase 1 trial of its osteoporosis patch.

Related stories